CareStart Covid-19 Antigen Test

CareStart Covid-19 Antigen Test

To effectively end the SARS-CoV-2 pandemic, systematic screening and detection of both clinical and asymptomatic COVID-19 cases is critical. Particularly, the identification of subclinical or asymptomatic cases is important to reduce or stop the infection because these individuals may transmit the virus. As an intended point-of-care (POC) designated test with a 10 min processing time, CareStart™ COVID-19 Antigen Test allows effective screening of COVID-19 infection on a large scale.

Features

• Detect SARS-CoV-2 nucleocapsid protein antigen with ultra high performance
• Identify acute infection with 88.4% sensitivity and 100% specificity
• EUA granted by FDA
• No equipment required
• Rapid results within 10 minutes
• Minimally invasive specimen collection (nasopharyngeal swabs) Intended at POC setting (i.e., in patient care settings) by medical professionals

Note for Healthcare Providers: the CARES Act reimburses each test (CARES Act Category 1 CPT codes 86328 and 86769). If providers are out of network, private insurers are required to reimburse.